4//SEC Filing
Baroldi Joseph 4
Accession 0000874015-26-000016
CIK 0000874015other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:34 PM ET
Size
8.4 KB
Accession
0000874015-26-000016
Insider Transaction Report
Form 4
Baroldi Joseph
EVP, Chief Business Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2026-01-02+19,350→ 19,350 totalExercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (19,350 underlying) - Award
Non-Qualified Stock Option (right to buy)
2026-01-02+2,600→ 2,600 total(indirect: By Spouse)Exercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (2,600 underlying)
Footnotes (2)
- [F1]Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
- [F2]Grant on 01/02/2026 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001813775
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:34 PM ET
- Size
- 8.4 KB